To confirm whether this phenomenon existed in NSCLC tumor tissue between different PCSK9 expression levels and CD8+ T cells, we next performed multiplexed immunofluorescent staining to show tumor cells and CD8+ T cells in NSCLC tissue with different PCSK9 expression levels. This evidence concerns the gene CD8A and neoplasm.